Collegium Pharmaceutical, Inc (COLL) stock
COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3043% below fair value
$25.32+0.37 (+1.48%)
Close on Nov 13, 2026Market cap $824.31MP/E 25.3Yield –
Collegium Pharmaceutical market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Collegium Pharmaceutical's market cap was $806.28M on Nov 11, 2026, against $1.48B a year earlier. Over the last 5 years it ranged from $529.88M to $1.48B, with a median of $936.32M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $806.28M | -44.9% |
| 2025 | Dec 31, 2025 | $1.46B | +58.5% |
| 2024 | Dec 31, 2024 | $923.39M | -9.3% |
| 2023 | Dec 29, 2023 | $1.02B | +29.9% |
| 2022 | Dec 30, 2022 | $783.59M | +20.5% |
| 2021 | Dec 31, 2021 | $650.01M | -6.1% |
| 2020 | Dec 31, 2020 | $692.58M | +0.4% |
| 2019 | Dec 31, 2019 | $689.92M | +20.9% |
| 2018 | Dec 31, 2018 | $570.82M | +0.5% |
| 2017 | Dec 29, 2017 | $567.92M | +54.6% |
| 2016 | Dec 30, 2016 | $367.28M | -35.4% |
| 2015 | Dec 31, 2015 | $568.92M | – |
See a number that looks wrong?